8-K current report · filed Nov 9, 2026

ORASURE TECHNOLOGIES INC (OSUR) 8-K Current Report: November 9, 2026

Item 2.02Item EX-99.1OSUR overview

Short answer

ORASURE TECHNOLOGIES INC (OSUR) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). OraSure announced consolidated results for the quarter ended September 30, 2026.

ORASURE TECHNOLOGIES INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • OraSure announced consolidated results for the quarter ended September 30, 2026
  • Detailed financial results and management commentary are contained in Exhibit 99.1
  • Investors should review the exhibit for revenue, profitability, guidance and operating trends

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $30.9M, up 14% year over year, led by Diagnostics growth of 16% and Sample Management Solutions growth of 21%
  • GAAP gross margin expanded to 45.2% from 43.5%, reflecting operational efficiencies and improved fixed-cost absorption
  • GAAP operating loss narrowed to $13.0M from $16.1M, but non-GAAP net loss widened to $10.1M from $9.8M
  • Initial orders for Colli-Pee Dx and OraQuick Ebola 2.0 create early commercial validation for new growth platforms
  • Q4 revenue guidance $30.0M to $32.0M, with full-year 2027 growth expected to accelerate; cash totaled $148.2M at September 30, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ORASURE TECHNOLOGIES INC 8-K filings

Get the next OSUR 8-K as it lands

Follow OSUR for push alerts, or ask the research agent what this filing means.